Navigation Links
Stem Cell Treatment Has Potential to Help Parkinson’s Disease Unexpected Brain Area
Date:3/28/2017

Currently symptomatic therapies for Parkinson’s Disease (PD) produce unwanted side effects and diminished effectiveness over time. A recent study published in STEM CELLS suggests that human neural stem cell (hNSC) transplantation could help to treat PD by stimulating subventricular zone (SVZ) stem cells to produce more neural cells.

Strategies involving transplantation of these cells into the affected brain regions hold great promise; however, the exact mechanisms behind hNSCs’ success are not fully understood.

Neural stem cells are self-renewing and can differentiate into any type of neural cell, such as neurons and glial cells. With their ability to rescue dysfunctional neural pathways, NSCs are an ideal source for grafting and the development of novel therapies.

A team led by Renzhi Wang from Peking Union Medical College Hospital and Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences presented an animal model study to improve understanding of the pathogenesis of PD. They also reported that the novel mechanism of action of transplanted hNSCs may prove helpful in the development of stem cell-based therapeutics for PD and other neurodegenerative diseases.

Using a high-throughout quantitative approach, proteome profiles of PD-related brain regions were characterized in mice. These included the substantia nigra, striatum, olfactory bulb, and, significantly, the subventricular zone (SVZ). This analysis showed a profound disturbance of the SVZ proteome, confirming the involvement of the SVZ in PD.

###

The full article, “Intrastriatal transplantation of human neural stem cells restores the impaired subventricular zone in parkinsonian mice,” can be accessed at: http://onlinelibrary.wiley.com/doi/10.1002/stem.2616/full.

About the Journal: STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. The journal covers all aspects of stem cells: embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; cancer stem cells; the stem cell niche; stem cell epigenetics, genomics and proteomics; and translational and clinical research. STEM CELLS is co-published by AlphaMed Press and Wiley-Blackwell.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes three internationally renowned peer-reviewed journals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. STEM CELLS® (http://www.StemCells.com) is the world's first journal devoted to this fast paced field of research. THE ONCOLOGIST® (http://www.TheOncologist.com) is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. STEM CELLS TRANSLATIONAL MEDICINE® (http://www.StemCellsTM.com) is dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.

About Wiley-Blackwell: Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world’s leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed

Read the full story at http://www.prweb.com/releases/2017/03/prweb14186331.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
2. Non-Toxic Rust Remover Offers Complimentary Samples, My Cleaning Products Relates Its Cuts Rust Treatment Expenses by 50%
3. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
4. Surgeons worldwide gather online to discuss treatments for trauma
5. Spinifex Receives $1.5m in R&D Tax Incentive for Research Activities Related to the Discovery of Treatments for Pain
6. Leading Biotoxin & Mold Illness Authority Creates Certification Process for Treatment Protocol
7. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
8. Probiotic Action Announces New Use for Their Adult Acne Treatment and Explains its Beauty Benefits for Women
9. Dermatology Associates Medical Group in Beverly Hills Announces Safe, Fast Anti-Aging Laser Treatment
10. “Scientific And Medical Research On The Successful Treatment Of Type 1 + 2 Diabetes With Alkaline Reduced Water” is Reviewed in Today’s Bawell Water Ionizer Health Report
11. Chemical Publishing Company Partners with Author Cloudware for a Digital eBook Distribution for Water Treatment, Waste Water Treatment, and Cooling Water Treatment Titles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2018)... ... August 01, 2018 , ... ... significant impact of a proprietary biofield energy treated supplement that potentially improves ... biomarkers for systemic and organ-specific inflammation, as well as, immune function response. ...
(Date:7/27/2018)... ... July 27, 2018 , ... ... Group (BRAG®) and representatives of the Biotechnology Innovation Organization (BIO) met with ... white paper, “Proposal for a Toxic Substances Control Act (TSCA) Inventory Representation ...
(Date:7/25/2018)... Calif. (PRWEB) , ... July 25, 2018 , ... ... in vivo research utilizing its state-of-the-art Digital Vivarium™ and Vium Cloud approach to ... Ph.D., to Chief Scientific Officer. Additionally, the company announced the appointment of Jeff ...
(Date:7/24/2018)... Neb. (PRWEB) , ... July 23, 2018 , ... ... impact of a biofield energy treated nutraceutical to increase immunity and improve anti-inflammatory, ... as, immune function response assessed in the preclinical research were significantly reduced. Results ...
Breaking Biology Technology:
(Date:8/7/2018)... ... August 07, 2018 , ... Nanomedical ... announces a new publication titled, “Synthetic Molecules for Disruption of the Myc ... prominently features use of Agile R100, described as a “ field-effect transistor (Bio-FET) ...
(Date:8/1/2018)... ... , ... Dr. Asher Kimchi, Founder and Chairman of the International Academy ... at the 23rd World Congress on Heart Disease held in Boston, MA, USA. In ... Distinguished Fellowship Awards. , Dr. Asher Kimchi, together with Chairman Dr. John A. Elefteriades, ...
(Date:7/31/2018)... ... July 31, 2018 , ... ACEA Biosciences, is a privately owned biotechnology company ... introduced the xCELLigence RTCA S16, which the ideal entry level model for exploratory studies ... S16can be placed in any standard CO2 tissue culture incubator. The user friendly ...
Breaking Biology News(10 mins):